Al Habib Q2 profit up 6.5% to SAR 591M on 31% revenue surge

Riyadh, Saudi Arabia — Dr. Sulaiman Al Habib Medical Services Group Company posted a 6.48% year-on-year rise in net profit for Q2 2025, reaching SAR 591.02 million, up from SAR 555.03 million in Q2 2024. Profit also rose 6.11% quarter-on-quarter, up from SAR 557.01 million in Q1 2025.

Al Habib Q2 Profit Climbs 6.5% on Hospital and Pharmacy Growth

Revenue jumped 31.5% year-on-year to SAR 3,384.33 million, driven by higher hospital admissions and pharmacy sales. Although fixed costs from new facilities pressured margins, EBITDA climbed 25.64% to SAR 858.25 million. This reflects improved operational scale.

Al Habib H1 Earnings Up 3.8%, Reinforcing Strategic Expansion

For the first half of 2025, net profit rose 3.8% year-on-year to SAR 1,148.03 million, compared with SAR 1,105.97 million a year earlier. Revenue rose 28.4%, showing strength across all healthcare segments. However, expansion-related costs continued to weigh on margins.

What This Means for Investors

Steady growth: Revenue and net income continued to rise, driven by sustained healthcare demand.
Temporary margin pressure: New facility costs are compressing margins, though this should ease as sites mature.
Efficiency gains: EBITDA growth signals improved scale and cost management.
Resilient outlook: Consistent results suggest earnings stability during the group’s expansion.

THE SAUDI STANDARD’S VIEW: Al Habib’s Results Reflect Scalable Healthcare Excellence

The Al Habib Q2 profit increased to SAR 591.02 million—alongside a 31.5% revenue surge—highlighting the strength of Saudi Arabia’s leading private healthcare provider. These results demonstrate how strategic expansion and integrated care delivery drive patient outcomes and investor value under Vision 2030.

Volume-driven growth: Rising patient numbers and pharmacy sales powered revenue, validating the Group’s full-service care model. This performance, despite pressure from fixed expansion costs, confirms sound execution.
Quarterly improvement: The 6.1% profit gain from Q1 signals that new facilities contribute meaningfully to earnings. This reflects effective onboarding and strategic capital deployment.
H1 resilience: Al Habib’s first-half profit of SAR 1.148 billion reaffirms its role as a stable and profitable healthcare operator, even amid rapid scaling.
Policy alignment: The Group’s momentum supports national goals of expanding private-sector healthcare, relieving public capacity, and improving service standards.

Al Habib’s performance demonstrates how scale, integration, and specialization can coexist with strong profitability. As Saudi Arabia’s healthcare transformation advances, the company remains a key driver of sector excellence and investor trust.

• Explore dividend payouts and healthcare sector updates in Saudi Arabia